Skip to main content
Equibles
VREOF logo

VREOF · Vireo Growth Inc. · Metrics

Track VREOF — free

Use VREOF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VREOF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.01 +0.01 (+0.11%) At close · Oct 19
Rebalance outlook locked
Market Cap
$431.07M
Shares
48.06M
Volume · Oct 19 12.7K Avg daily vol (3M) 45.84K

VREOF metrics

52 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.01
Market cap
$431.07M

Price action

20 metrics
Price change (1W)
-4.1%
Price change (30D)
-22.9%
Price change (3M)
-8.0%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
51.0%
Annualized volatility (3M)
52.8%
Beta
—
RSI (14D)
35.2
Price vs SMA 50
-16.1%
Price vs SMA 200
—
Avg volume (3M)
45,880
Relative volume
0.9
Average dollar volume
$499,825

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
48.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 118.3%
P / book
1.0
reciprocal yield 102.3%
FCF yield
-26.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
16.5
reciprocal yield 6.1%
Earnings yield
-15.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
48.6%
Operating margin
0.3%
Trailing 12 months
Net margin
-13.1%
Gross profit (TTM)
$248.90M
Operating profit (TTM)
$1.65M
Net income (TTM)
−$67.11M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-22.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+335.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$511.67M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+141.9%
Year over year · more shares
Revenue CAGR (3Y)
+53.3%
Revenue CAGR (5Y)
+40.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-15.2%
Return on assets
-5.3%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
$25.76M
Free cash flow (TTM)
−$116.31M
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$122.70M
Total assets
$1.27B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$26.21M
Capital expenditures (TTM)
$142.52M
R&D (TTM)
—
SG&A (TTM)
$163.79M
Stock compensation (TTM)
$27.51M
R&D / revenue
—
Stock compensation / revenue
5.4%

Ownership (13F)

9 metrics
13F filers
0
13F filer change QoQ
-1
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
20 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1771706 CUSIP 92767B204 Visit website Investor relations